RECBIO-B Receives CSRC Filing Notice for H-Share Full Circulation Plan

Deep News
02/02

RECBIO-B (02179) announced that the company has recently received a filing notice from the China Securities Regulatory Commission (CSRC) dated January 13, 2026, regarding its H-share full circulation plan.

According to the filing notice, the company has completed the filing with the CSRC for the conversion of a total of 142 million non-tradable shares held by 28 shareholders into H-shares.

The filing notice is valid for 12 months starting from January 13, 2026.

The company will apply to The Stock Exchange of Hong Kong for the approval to list and trade the relevant H-shares.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10